Quynh-Thu Le
Chairs NRG Oncology, the largest US radiotherapy cooperative group, and leads head and neck de-escalation trials.
Overview
Quynh-Thu Le is group chair of NRG Oncology, which runs the national radiotherapy-based trials in the United States, and has led NRG head and neck studies including HN002 and HN005 on de-escalating radiotherapy for HPV-positive oropharyngeal cancer. Her laboratory studies tumour hypoxia and galectin-1 as targets and biomarkers, and she chairs radiation oncology at Stanford.
Pages like this
not linked directly; found by shared links- PairingCaution: de-escalating radiation on HPV status alone
Shares NRG-HN002 & NRG-HN005 (HPV+ de-escalation), IMRT / IGRT (modern external beam), Head and neck squamous cell carcinoma.
- IdeactHPV-DNA-adapted de-escalation of chemoradiation
Shares NRG-HN002 & NRG-HN005 (HPV+ de-escalation), IMRT / IGRT (modern external beam), Head and neck squamous cell carcinoma.
- PersonJean Bourhis
Shares IMRT / IGRT (modern external beam), Head and neck squamous cell carcinoma and the tags radiotherapy, head-and-neck.
- PersonJeffrey D. Bradley
Shares IMRT / IGRT (modern external beam) and the tags radiotherapy, nrg-oncology.
- PersonHisham Mehanna
Shares IMRT / IGRT (modern external beam), Head and neck squamous cell carcinoma and the tag head-and-neck.
- ProductAmifostine
Shares IMRT / IGRT (modern external beam), Head and neck squamous cell carcinoma.
- PersonA. Murray Brunt
Shares IMRT / IGRT (modern external beam) and the tag radiotherapy.
- TrialTrilynX
Shares IMRT / IGRT (modern external beam), Head and neck squamous cell carcinoma.